Oric Pharmaceuticals Inc. (ORIC) News

Oric Pharmaceuticals Inc. (ORIC): $4.75

0.28 (+6.26%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ORIC to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

Filter ORIC News Items

ORIC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ORIC News Highlights

  • For ORIC, its 30 day story count is now at 6.
  • Over the past 25 days, the trend for ORIC's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
  • The most mentioned tickers in articles about ORIC are COMP and TREX.

Latest ORIC News From Around the Web

Below are the latest news stories about Oric Pharmaceuticals Inc that investors may wish to consider to help them evaluate ORIC as an investment opportunity.

2 Falling Knives to Catch

ORIC Pharmaceuticals Inc. and Ondas Holdings Inc. have positive ratings despite falling more than 59% over the past year

Yahoo | February 22, 2022

ORIC Pharmaceuticals to Participate in the Guggenheim 2022 Oncology Conference

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in a virtual fireside chat at the Guggenheim 2022 Oncology Conference on Thursday, February 10, 2022, at 2:00 p.m. ET. A live webcast of the fireside chat will be available through the investor section of the comp

Yahoo | February 2, 2022

Emerald Advisers, Llc Buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA Pharmaceuticals ...

Investment company Emerald Advisers, Llc (Current Portfolio) buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA Pharmaceuticals Inc, HireRight Holdings Corp, Arhaus Inc, sells Chegg Inc, ORIC Pharmaceuticals Inc, BellRing Brands Inc, Trex Co Inc, Arena Pharmaceuticals Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Emerald Advisers, Llc.

Yahoo | February 2, 2022

Emerald Mutual Fund Advisers Trust Buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA ...

Leola, PA, based Investment company Emerald Mutual Fund Advisers Trust (Current Portfolio) buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA Pharmaceuticals Inc, Karuna Therapeutics Inc, HireRight Holdings Corp, sells Chegg Inc, BellRing Brands Inc, Echo Global Logistics Inc, Tetra Tech Inc, ORIC Pharmaceuticals Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Emerald Mutual Fund Advisers Trust.

Yahoo | February 2, 2022

Companies Like ORIC Pharmaceuticals (NASDAQ:ORIC) Are In A Position To Invest In Growth

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Yahoo | February 1, 2022

10 Best Biotech and AI Stocks To Buy According To Quant Billionaire Jim Simons

Euclidean Capital is the family office of billionaire hedge fund manager James “Jim” Simons. The hedge fund manages the private fortunes of Jim Simons, the 28th richest person in the world with a personal net worth of $24.4 billion as of January 28. Jim Simons is said to have revolutionized investing when he left academics […]

Yahoo | January 28, 2022

ORIC Pharmaceuticals Announces Regulatory Clearance of Clinical Trial Application for ORIC-114 in Advanced Solid Tumors with EGFR or HER2 Exon 20 Alterations or HER2 Amplifications

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced clearance of its Clinical Trial Application (CTA) by the regulatory authorities of the Republic of Korea for ORIC-114, a brain penetrant, orally bioavailable, irreversible inhibitor designed to selectively target EGFR and HER2 with high potency a

Yahoo | January 25, 2022

Regents Of The University Of California Buys Unity Software Inc, Airbnb Inc, QuantumScape Corp, ...

Oakland, CA, based Investment company Regents Of The University Of California (Current Portfolio) buys Unity Software Inc, Airbnb Inc, QuantumScape Corp, ORIC Pharmaceuticals Inc, Calyxt Inc, sells Upstart Holdings Inc, Nurix Therapeutics Inc, RAPT Therapeutics Inc, Pinduoduo Inc, View Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Regents Of The University Of California.

Yahoo | January 24, 2022

ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones

ORIC-101 program on track for updates from both ongoing clinical trials in first half of 2022 Initial Phase 1b data from ORIC-533 in multiple myeloma, ORIC-114 in EGFR/HER2 cancers and ORIC-944 in prostate cancer expected in first half of 2023 Cash and investments of $280.8 million expected to fund operating plan into first half of 2024 SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused

Yahoo | January 10, 2022

ORIC Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO and SAN DIEGO, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that Jacob Chacko, M.D., chief executive officer, will present a company overview at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 3:00 p.m. ET. A live webcast of the company presentation will be available thr

Yahoo | January 4, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6031 seconds.